(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.16%) $82.50
(1.43%) $2.06
(-0.50%) $2 345.80
(-1.01%) $27.38
(-0.07%) $960.80
(0.12%) $0.934
(0.21%) $11.01
(0.07%) $0.797
(0.01%) $93.31
-4.59% $ 1.040
Live Chart Being Loaded With Signals
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors...
Stats | |
---|---|
Volumen de hoy | 375 405 |
Volumen promedio | 1.22M |
Capitalización de mercado | 38.39M |
EPS | $0 ( 2024-04-04 ) |
Próxima fecha de ganancias | ( $-0.300 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.370 |
ATR14 | $0.00800 (0.78%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-02 | Gilead Sciences, Inc. | Buy | 485 250 | Common Stock |
2024-04-02 | Gilead Sciences, Inc. | Buy | 3 882 450 | Prefunded Warrants (right to buy) |
2024-03-27 | Gilead Sciences, Inc. | Sell | 0 | Common Stock |
2024-02-08 | Atlas Venture Fund Xi, L.p. | Sell | 733 | Common Stock |
2024-02-08 | Atlas Venture Fund Xi, L.p. | Sell | 267 | Common Stock |
INSIDER POWER |
---|
91.69 |
Last 95 transactions |
Buy: 18 066 351 | Sell: 51 747 162 |
Volumen Correlación
Xilio Therapeutics, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
AMRB | 0.872 |
OTRK | 0.864 |
NEON | 0.858 |
SHYF | 0.843 |
PPTA | 0.841 |
POET | 0.825 |
UBFO | 0.825 |
LWAC | 0.82 |
PBPB | 0.82 |
NVCN | 0.819 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Xilio Therapeutics, Inc. Correlación - Moneda/Commodity
Xilio Therapeutics, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.90M (0.00 %) |
EPS: | $-2.78 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.90M (0.00 %) |
EPS: | $-2.78 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.85M (0.00 %) |
EPS: | $-3.19 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-13.52 |
Financial Reports:
No articles found.
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico